monobenzone has been researched along with Hypopigmentation in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Erdoğan, A; Mutlu, HS; Solakoğlu, S | 1 |
| Dong, J; Lai, Y; Shang, J; Yue, Y; Zhang, X; Zhong, H | 1 |
| Li, QL; Liang, TS; Liu, XT; Lv, XT; Tang, N; Wang, GE; Wen, WL; Wu, YH | 1 |
| Harris, JE | 1 |
| Arowojolu, OA; Elbuluk, N; Manga, P; Orlow, SJ | 1 |
| Wang, S; Xu, A; Zhu, Y | 1 |
| Luiten, RM; Melief, CJ; van den Boorn, JG | 1 |
| Buggiani, G; Lotti, T; Prignano, F | 1 |
| Bajaj, AK; Chatterjee, AK; Gupta, SC | 1 |
| Hori, Y; Urabe, K | 1 |
| Gonzales, V; Lubowe, IL; Morse, JL | 1 |
3 review(s) available for monobenzone and Hypopigmentation
| Article | Year |
|---|---|
Chemical-Induced Vitiligo.
Topics: Autoimmunity; Catechols; Hair Dyes; Humans; Hydroquinones; Hypopigmentation; Phenols; Phenylenediamines; Skin Lightening Preparations; Vitiligo | 2017 |
Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunity.
Topics: Autoimmunity; Humans; Hydroquinones; Hypopigmentation; Melanoma; Models, Biological; Monophenol Monooxygenase; Vitiligo | 2011 |
Dyschromatosis.
Topics: Age Factors; Amyloidosis; Cloning, Molecular; Cyclopropanes; Diagnosis, Differential; Extremities; Foot Dermatoses; Hand Dermatoses; Humans; Hydroquinones; Hyperpigmentation; Hypopigmentation; Infant, Newborn; Japan; Pigmentation Disorders; Skin Diseases; Xeroderma Pigmentosum | 1997 |
8 other study(ies) available for monobenzone and Hypopigmentation
| Article | Year |
|---|---|
Autologously transplanted dermis-derived cells alleviated monobenzone-induced vitiligo in mouse.
Topics: Animals; Dermis; Disease Models, Animal; Hair Follicle; Hydroquinones; Hypopigmentation; Melanins; Mice; Mice, Inbred C57BL; Vitiligo | 2022 |
Optimization of Monobenzone-Induced Vitiligo Mouse Model by the Addition of Chronic Stress.
Topics: Animals; Disease Models, Animal; Hydroquinones; Hypopigmentation; Melanocytes; Mice; Skin; Vitiligo | 2023 |
Restraint stress promotes monobenzone-induced depigmentation in mice via the activation of glucocorticoid receptor/macrophage migration inhibitory factor signaling pathway.
Topics: Animals; Hypopigmentation; Macrophage Migration-Inhibitory Factors; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Receptors, Glucocorticoid; Signal Transduction; Vitiligo | 2023 |
The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone.
Topics: Antioxidants; Cell Line; Cell Survival; Dimethyl Fumarate; Humans; Hydroquinones; Hypopigmentation; Melanocytes; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidants; Oxidative Stress; Peroxiredoxin VI; Skin; Vitiligo | 2017 |
A mouse model of vitiligo induced by monobenzone.
Topics: Animals; Autoimmunity; CD8-Positive T-Lymphocytes; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroquinones; Hypopigmentation; Melanocytes; Mice; Mice, Inbred C57BL; Skin; Vitiligo | 2013 |
New and experimental treatments of vitiligo and other hypomelanoses.
Topics: Dermatologic Agents; Humans; Hydroquinones; Hypopigmentation; Keratinocytes; Laser Therapy; Melanocytes; Phototherapy; Skin Pigmentation; Skin Transplantation; Ultraviolet Therapy; Vitiligo | 2007 |
Footwear depigmentation.
Topics: Dermatitis, Allergic Contact; Humans; Hydroquinones; Hypopigmentation; Shoes | 1996 |
Diffuse leukoderma following use of monobenzone.
Topics: Adult; Facial Dermatoses; Female; Humans; Hydroquinones; Hyperpigmentation; Hypopigmentation | 1965 |